McKesson Corporation (MCK) Stock

About McKesson Corporation

McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.

McKesson Corporation is led by CEO Brian S. Tyler, employs 44,000 people, headquartered in Irving, US, publicly traded since 1994.

McKesson Corporation (MCK) stock trades at $888.56 with a market capitalization of $104.03B. The stock is valued at a price-to-earnings (P/E) ratio of 23.00, price-to-book of -49.95, price-to-sales of 0.26. Over the past 52 weeks the stock has ranged between $637.00 and $999.00, and currently trades 11.1% below its 52-week high. It pays a dividend yielding 0.42%.

On profitability, McKesson Corporation generates a return on equity (ROE) of -265.44%, return on capital employed of 41.62%, an operating margin of 1.54%, a net profit margin of 1.18%.

In its most recent fiscal year, McKesson Corporation reported annual revenue of $403.4B, net profit of $4.8B, revenue has compounded at 11.1% a year over the last five years.

The balance sheet shows a debt-to-equity ratio of -3.97 — a conservative balance sheet with little leverage risk, a current ratio of 0.85, total assets of $82.3B, $4.0B in cash and equivalents.

MCK has an average daily trading volume of 1,179,449 shares, a beta of 0.32 (less volatile than the overall market).

Official website: www.mckesson.com